Article Text

PDF
Oestrogen and progestin increased urge and stress incontinence in postmenopausal women with coronary heart disease

Statistics from Altmetric.com

OpenUrlPubMedWeb of Science

Q In postmenopausal women with coronary heart disease, does oestrogen and progestin treatment affect the risk of stress and urge urinary incontinence (UI)?

METHODS

Embedded ImageDesign:

secondary analysis of a randomised placebo controlled trial (Heart Estrogen/progestin Replacement Study [HERS]).

Embedded ImageAllocation:

{concealed}.*

Embedded ImageBlinding:

blinded {patients, investigators, and outcome assessors}.*

Embedded ImageFollow up period:

4–48 months.

Embedded ImageSetting:

20 clinical centres in the US.

Embedded ImagePatients:

1228 postmenopausal women <80 years of age who had coronary heart disease, an intact uterus, and reported no episodes of UI within the past week. {Exclusion criteria included use of oral, parenteral, vaginal, or transdermal hormones within 3 months; …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.